The US Food and Drug Administration has released a Public Health Notification about deaths associated with Radio Frequency Ablation of Lung Tumors.
The FDA has received several reports of patients dying after treatment with radio frequency ablation of lung tumors (RF Ablation). Patient selection, subsequent treatment and technical use of the RF device, including placement and operation, may be contributing factors.
FDA has cleared many RF ablation devices as tools for general ablation of soft tissue by thermal coagulation necrosis. These devices have also been cleared for certain specific indications, including partial or complete ablation of non-resectable liver lesions and palliation of pain associated with metastatic lesions involving bone. It is important to note that RF ablation Devices have NOT been cleared specifically for lung tumor ablation.
Discuss this information with your doctor before getting radio frequency ablation for the treatment of lung tumors.
If you or a loved one has experienced an adverse event after RF Ablation of lung tumors, you may consider contacting an attorney who can look into the matter to find out if this was possibly a case of medical malpractice.